Litmys Managing Partner Harris Kaplan will attend BioFuture 2026, taking place October 27–28, 2026, in New York City.

Organized by Demy-Colton, BioFuture brings together innovators, investors, and industry leaders to explore the emerging technologies, scientific advancements, and business strategies shaping the future of biopharma. The event features thought-provoking discussions, company presentations, and one-on-one partnering opportunities across biotechnology, digital health, artificial intelligence, and other evolving areas of healthcare.

As the pace of innovation accelerates, companies face growing pressure to demonstrate not only the clinical potential of their products but also their ability to achieve meaningful commercial success. Understanding market dynamics, stakeholder expectations, and the factors that influence real-world adoption is increasingly important for making informed development and investment decisions.

Harris looks forward to engaging with biotech leaders and investors on how earlier commercial assessment can help companies better understand market opportunity, identify potential adoption barriers, and build more credible commercialization strategies.

If you'll be at the conference and want to connect, please reach out.